Access to peptides eased despite FDA opposition
WASHINGTON -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration…
DO
By Daniel Okafor · Regulatory Correspondent
Oct 29 04:37 ETSource: Northwest Arkansas Democrat-Gazette
From the source
Read at nwaonline.comAccess to peptides eased despite FDA opposition
WASHINGTON -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development.
